- Home
- ATNF vs PRFX Comparison
ATNF vs PRFX Comparison
Compare ATNF & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- PRFX
- Stock Information
- Founded
- ATNF 2016
- PRFX 2007
- Country
- ATNF United States
- PRFX Israel
- Employees
- ATNF N/A
- PRFX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- ATNF Health Care
- PRFX Health Care
- Exchange
- ATNF Nasdaq
- PRFX Nasdaq
- Market Cap
- ATNF 1.8M
- PRFX 1.6M
- IPO Year
- ATNF N/A
- PRFX 2020
- Fundamental
- Price
- ATNF $1.42
- PRFX $0.64
- Analyst Decision
- ATNF
- PRFX Strong Buy
- Analyst Count
- ATNF 0
- PRFX 1
- Target Price
- ATNF N/A
- PRFX $12.00
- AVG Volume (30 Days)
- ATNF 46.0K
- PRFX 676.0K
- Earning Date
- ATNF 11-07-2024
- PRFX 11-13-2024
- Dividend Yield
- ATNF N/A
- PRFX N/A
- EPS Growth
- ATNF N/A
- PRFX N/A
- EPS
- ATNF N/A
- PRFX N/A
- Revenue
- ATNF N/A
- PRFX N/A
- Revenue This Year
- ATNF N/A
- PRFX N/A
- Revenue Next Year
- ATNF $54.15
- PRFX N/A
- P/E Ratio
- ATNF N/A
- PRFX N/A
- Revenue Growth
- ATNF N/A
- PRFX N/A
- 52 Week Low
- ATNF $1.31
- PRFX $0.57
- 52 Week High
- ATNF $12.03
- PRFX $20.16
- Technical
- Relative Strength Index (RSI)
- ATNF 35.64
- PRFX 30.24
- Support Level
- ATNF $1.38
- PRFX $0.60
- Resistance Level
- ATNF $1.58
- PRFX $0.65
- Average True Range (ATR)
- ATNF 0.16
- PRFX 0.07
- MACD
- ATNF -0.05
- PRFX 0.03
- Stochastic Oscillator
- ATNF 4.60
- PRFX 20.14
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation and fibrosis by employing innovative research, and, where appropriate, combination therapy.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.